Katia Alves

Katia Alves is a seasoned medical professional with extensive experience in the pharmaceutical and clinical research sectors. Currently serving as Senior Medical Director at NOVAVAX INC since July 2021, Katia has held similar senior positions at Assembly Biosciences, Inc. and AbbVie, focusing on antiviral and infectious diseases. Previous roles include Medical Director for Merck and Vertex Pharmaceuticals, where responsibilities spanned hepatology and clinical development. Early career experiences include work as an Associate Medical Director at VaxGen, Inc. and a Research Fellow at UCSF. Katia's educational background includes a Fellowship in Clinical Pharmacology from Stanford University, an MPH in Epidemiology from UC Berkeley, and a Master's in Medicine from Universidade de Sao Paulo, complemented by extensive training in infectious diseases.